Factors that affect adherence to surveillance colonoscopy in patients with inflammatory bowel disease

Inflammatory Bowel Diseases

Volumn 19, Issue 3, 2013, Pages 534-539

  Friedman, Sonia ^a   Cheifetz, Adam S ^b   Farraye, Francis A ^c   Banks, Peter A ^a   Makrauer, Frederick L ^a   Burakoff, Robert ^a   Farmer, Barbara ^a   Torgersen, Leanne N ^a   Wahl, Kelly E ^d  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^c BOSTON MEDICAL CENTER   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Adherence; Colonoscopy; Crohn's disease; Dysplasia; Surveillance; Ulcerative colitis

Indexed keywords

ADULT; AGED; ARTICLE; CANCER SCREENING; COLON CANCER; COLON DISEASE; COLON DYSPLASIA; COLONOSCOPY; CONTROLLED STUDY; CROHN DISEASE; CROSS-SECTIONAL STUDY; DISEASE DURATION; DISEASE SURVEILLANCE; DYSPLASIA; FEMALE; HEALTH BELIEF; HEALTH CARE COST; HEALTH INSURANCE; HUMAN; INFORMATION DISSEMINATION; JOB STRESS; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; MENTAL STRESS; MULTICENTER STUDY; PATIENT ATTITUDE; PATIENT COMPLIANCE; PERSONAL EXPERIENCE; PRIORITY JOURNAL; SELF REPORT; ULCERATIVE COLITIS;

ADENOMA; ADULT; AGED; AGED, 80 AND OVER; COLITIS, ULCERATIVE; COLONOSCOPY; COLORECTAL NEOPLASMS; CROHN DISEASE; CROSS-SECTIONAL STUDIES; FEMALE; HEALTH CARE SURVEYS; HEALTH SERVICES ACCESSIBILITY; HUMANS; MALE; MIDDLE AGED; MOTIVATION; PATIENT COMPLIANCE; QUESTIONNAIRES; SELF REPORT;

EID: 84876360827     PISSN: 10780998     EISSN: 15364844     Source Type: Journal    
DOI: 10.1097/MIB.0b013e3182802a3c     Document Type: Article

References (18)

1. Eadon JA, Abrams KR, Mayberry JF. The risk of colorectal cancer in ulcerative colitis: a meta-analysis. Gut. 2001;48:526-535.
2. Rutter MD, Saunders BP, Wilkinson KH, et al. Thirty-year analysis of a colonoscopic surveillance program for neoplasia in ulcerative colitis. Gastroenterology. 2006;130:1030-1038.
3. Friedman S, Rubin PH, Bodian C, et al. Screening and surveillance colonoscopy in chronic Crohn's colitis: results of a surveillance program spanning 25 years. Clin Gastroenterol Hepatol. 2008;6:993-998.
4. Jess T, Loftus EV Jr, Velayos FS, et al. Risk of intestinal cancer in inflammatory bowel disease: a population-based study from Olmstead County, Minnesota. Gastroenterology. 2006;130:1039-1046.
5. Itzkowitz SH, Present DH; Crohn's and Colitis Foundation of America Colon Cancer in IBD Study Group. Consensus conference: colorectal cancer screening and surveillance in inflammatory bowel disease. Inflamm Bowel Dis. 2005;11:314-321.
6. Farraye F, Odze RD, Eaden J, et al. AGA technical review on the diagnosis and management of colorectal neoplasia in inflammatory bowel disease. Gastroenterology. 2010;138:746-774.
7. Farraye FA, Odze RD, Eaden J, et al. AGA medical position statement on the diagnosis and management of colorectal dysplasia in inflammatory bowel disease. Gastroenterology. 2010;138:738-745.
8. Friedman S, Cheifetz A, Farraye F, et al. Doctor message can alter patients' behavior and attitudes regarding inflammatory bowel disease and colon cancer. Inflamm Bowel Dis. 2012;18:1531-1539.
9. Centers for Disease Control and Prevention (CDC). Vital signs: colorectal cancer screening, incidence, and mortality-United States, 2002-2010. MMWR Morb Mortal Wkly Rep. 2011;60:884-889.
10. Meissner HI, Breen N, Klabunde CN, et al. Patterns of colorectal cancer screening uptake among men and women in the United States. Cancer Epidemiol Biomarkers Prev. 2006;15:389-394.
11. McLauchlan SA, Clements A, Austoker J. Patients' experiences and reported barriers to colonoscopy in the screening context-a systematic review of the literature. Patient Educ Couns. 2012;86:137-146.
12. Partin MR, Noorbaloochi S, Grill J, et al. The interrelationships between and contributions of background, cognitive, and environmental factors to colorectal cancer screening intolerance. Cancer Causes Control. 2010;21:1357-1368.
13. Wharam JF, Graves AJ, Landon BE, et al. Two-year trends in colorectal cancer screening after switch to a high-deductible health plan. Med Care. 2011;49:865-871.
14. Vienne A, Simon T, Cosnes J, et al. Low prevalence of colonoscopic surveillance of inflammatory bowel disease patients with longstanding extensive colitis: a clinical practice survey nested in the CESAME cohort. Aliment Pharmacol Ther. 2011;23:188-195.
15. Kottachchi D, Yung D, Marshall JK. Adherence to guidelines for surveillance colonoscopy in patients with ulcerative colitis at a Canadian Quaternary care hospital. Can J Gastroenterol. 2009;23:613-617.
16. Long MD, Lance T, Robertson D, et al. Colorectal cancer testing in the National Veterans Health Administration. Dig Dis Sci. 2012;57:288-293.
17. Ling BS, Schoen RE, Trauth JM, et al. Physicians encouraging colorectal screening: a randomized controlled enhanced office and patient management on compliance with colorectal cancer screening. Arch Intern Med. 2006;169:47-55.
18. Jibara G, Jandorf L, Fodera MB, et al. Adherence to physician recommendation to colorectal cancer screening colonoscopy among Hispanics. J Gen Intern Med. 2011;26:1124-1130.